# Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome

> **NCT03090620** · PHASE4 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 19 (actual)

## Conditions studied

- Anticholinergics Toxicity

## Interventions

- **DRUG:** Physostigmine
- **DRUG:** Lorazepam

## Key facts

- **NCT ID:** NCT03090620
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-30
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2021-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090620, "Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03090620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*